BioLife Solutions Inc (STU:BJX1)
€ 23.4 1.4 (6.36%) Market Cap: 1.10 Bil Enterprise Value: 1.10 Bil PE Ratio: 0 PB Ratio: 3.72 GF Score: 66/100

Q3 2019 Biolife Solutions Inc Earnings Call Transcript

Nov 12, 2019 / 09:30PM GMT
Release Date Price: €14.9 (-1.32%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Q3 2019 BioLife Solutions, Inc. Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Mr. Roderick de Greef, Chief Financial Officer. You may begin.

Roderick de Greef
BioLife Solutions, Inc. - CFO, COO & Secretary

Thank you, JP. Good afternoon, everyone, and thank you for joining us for the BioLife Solutions conference call to review the operating and financial results for the third quarter of 2019. Earlier this afternoon, we issued a press release which summarizes our financial results for the 3 and 9 months ended September 30, 2019. We also issued a press release this afternoon announcing our asset purchase of Custom Biogenic Systems or CBS.

As a reminder, during this call, we will make certain projections and other forward-looking statements regarding future events or the future financial performance of the company. These statements are subject to risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot